Cargando…
Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality
Clinical biomarkers that accurately predict mortality are needed for the effective management of patients with severe coronavirus disease 2019 (COVID-19) illness. In this study, we determine whether changes in D-dimer levels after anticoagulation are independently predictive of in-hospital mortality...
Autores principales: | Song, Xiaoyu, Ji, Jiayi, Reva, Boris, Joshi, Himanshu, Calinawan, Anna Pamela, Mazumdar, Madhu, Wisnivesky, Juan P., Taioli, Emanuela, Wang, Pei, Veluswamy, Rajwanth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942219/ https://www.ncbi.nlm.nih.gov/pubmed/34230883 http://dx.doi.org/10.1183/23120541.00018-2021 |
Ejemplares similares
-
3363 Prognostic Value of Immune-Related Biomarkers in Resected Non-Small Cell Lung Cancer
por: Veluswamy, Rajwanth R, et al.
Publicado: (2019) -
Real‐World longitudinal practice patterns in the use of PD‐1 and PD‐L1 inhibitors as First‐Line therapy in patients with Non‐Small cell lung cancer in the United States
por: Veluswamy, Rajwanth, et al.
Publicado: (2022) -
PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2020) -
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2019) -
Immunotherapy Outcomes in Individuals With Non–Small Cell Lung Cancer and Poor Performance Status
por: Veluswamy, Rajwanth, et al.
Publicado: (2022)